Chargement en cours...
Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who were naive to anticholinergics before the TIOtropium Safety and Performance In Respimat (TIOSPIR) trial may reflect patients seen in practice, in particular in primary care. In addition, investigating safety in these patients...
Enregistré dans:
| Publié dans: | NPJ Prim Care Respir Med |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4634206/ https://ncbi.nlm.nih.gov/pubmed/26540491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjpcrm.2015.67 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|